Gate2Brain at the VII SEQT Summer School

VII SEQT Summer School “Medicinal Chemistry and Chemical Biology in Drug DiscoveryGate2Brain

Our CEO, Meritxell Teixidó, participated as a speaker to the VII SEQT Summer School “Medicinal Chemistry and Chemical Biology in Drug Discovery: the Pharma Perspective” held on the 21 July.

A forum for scientific discussions aimed at introducing young researchers (both doctoral students and postdocs) working in the chemistry and health sciences related fields to the pharma industry. A seminar to learn about the latest research trends in pharmaceutical drug discovery and development.

The forum was organized by The Spanish Society of Medicinal Chemistry (SEQT), member of the European Federation of Medicinal Chemistry, and Enantia.

For Gate2Brain this workshop was a real opportunity to learn and interact with the scientific community.

/by
You might also like
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck
la start-up catalana una de las ganadoras del South Summit de salud en Valenciala VanguardiaGate2Brain one of the winners of the South Summit Health & Well-being
CataloniaBio & Health Teach GalaG2BCataloniaBio HT Gala 2023
It’s Gate2Brain second anniversary!! 🎂 The creativity, work and dedication of Gate2Brain's team can only be matched with its desire to bring medicines beyond barriers.Gate2BrainGate2Brain second anniversary
📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kidsi4kids Closing Event 2022
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness Series
Biotech New Frontiers Award 2022Gate2BrainG2B awarded with Biotech New Frontiers 2022
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

EADA Master students at Gate2Braininternship EadaThe Barcelona Deep Tech Award is part of the Barcelona Deep Tech Node initiative, which aims to support deep tech startups and spin-offs by facilitating their access to the market and international projection 🌐 and fostering the Deep Tech ecosystem in Barcelona.Barcelona ActivaGate2Brain finalist in the Barcelona Deep Tech Award